title: E-SHAP for refractory and relapsing lymphoma: influence of patient selection on response rate.
authors.forename: J
authors.initials: J
authors.lastname: Aparicio Urtasun
authors.forename: J
authors.initials: J
authors.lastname: Gómez Codina
authors.forename: C
authors.initials: C
authors.lastname: Molins Palau
authors.forename: M
authors.initials: M
authors.lastname: Pastor Borgoñón
authors.forename: I
authors.initials: I
authors.lastname: Maestu Maiques
authors.forename: B
authors.initials: B
authors.lastname: Munárriz Gandia
authors.forename: J
authors.initials: J
authors.lastname: Montalar Salcedo
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D011379:Prognosis; D015996:Survival Rate